Diagnostic Modalities Used in Diagnosing Gastroparesis: A Clinical Review

Ghazanfar, Haider; Allena, Nishant; Javed, Nismat; Ponnachan, Deny; Narasimhadevara, Sanjana; Komadur, Thrupthi; Ali, Ghazanfar; Acherjee, Trishna; Patel, Harish

doi:10.7759/cureus.30540

Search citation statements

Order By: Relevance

Paper Sections

Select...

Celiac Disease Novel Therapies1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Technolodzy próbują też wykorzystać możliwości modyfikacji genetycznej to reduce immunotoxic components of gluten (Ghazanfar et al, 2023;PubMed, 2024).…”

Section: Celiac Disease Novel Therapiesunclassified

From an understanding of etiopathogenesis to novel therapies—what is new in the treatment of celiac disease?

Skoracka,

Hryhorowicz,

Tovoli

et al. 2024

Front. Pharmacol.

View full text Add to dashboard Cite

Celiac disease, a chronic autoimmune disorder caused by genetic factors and exposure to gluten, is increasingly being recognized and diagnosed in both children and adults. Scientists have been searching for a cure for this disease for many years, but despite the impressive development of knowledge in this field, a gluten-free diet remains the only recommended therapy for all patients. At the same time, the increasing diagnosis of celiac disease in adults, which was considered a childhood disease in the 20th century, has opened a discussion on the etiopathology of the disease, which is proven to be very complex and involves genetic, immunological, nutritional, environmental and gut microbiota-related factors. In this review, we extensively discuss these factors and summarize the knowledge of the proposed state-of-the-art treatments for celiac disease to address the question of whether a better understanding of the etiopathogenesis of celiac disease has opened new directions for therapy.

show abstract

“…Technolodzy próbują też wykorzystać możliwości modyfikacji genetycznej to reduce immunotoxic components of gluten (Ghazanfar et al, 2023;PubMed, 2024).…”

Section: Celiac Disease Novel Therapiesunclassified

From an understanding of etiopathogenesis to novel therapies—what is new in the treatment of celiac disease?

Skoracka,

Hryhorowicz,

Tovoli

et al. 2024

Front. Pharmacol.

View full text Add to dashboard Cite

show abstract

Diagnostic Modalities Used in Diagnosing Gastroparesis: A Clinical Review

Cited by 1 publication

References 39 publications

From an understanding of etiopathogenesis to novel therapies—what is new in the treatment of celiac disease?

From an understanding of etiopathogenesis to novel therapies—what is new in the treatment of celiac disease?

Contact Info

Product

Resources

About